Inventor

BURTON DENNIS R

US48 patents

⚠️ This page may combine multiple inventors who share the name “BURTON DENNIS R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BURTON DENNIS R

SCRIPPS RESEARCH INST

Methods for producing antibody libraries using universal or randomized immunoglobulin light chains

Human neutralizing monoclonal antibodies to human immunodeficiency virus

Methods for producing antibody libraries using universal or randomized immunoglobulin light chains

Methods for producing antibody libraries using universal or randomized immunoglobulin light chains

Antibodies specific for native PrPSc

Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus

Human neutralizing monoclonal antibodies to human immunodeficiency virus

Human neutralizing monoclonal antibodies to respiratory syncytial virus

Human neutralizing monoclonal antibodies to respiratory syncytial virus

Human monoclonal antibodies to herpes simplex virus and methods therefor

Human neutralizing monoclonal antibodies to respiratory syncytial virus

Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus

Ligand capture-directed selection of antibody

Anti-dengue virus antibodies and compositions

Antibody for ligand capture assay

Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation

Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation

Antibodies specific for ungulate PrP

Antibodies specific for native PrPSc

Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation

Motif-grafted hybrid polypeptides and uses thereof

B cell receptor modification in B cells

THERACLONE SCIENCES INC

Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody

Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody

Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

INT AIDS VACCINE INITIATIVE

Broadly neutralizing antibody and uses thereof

Broadly neutralizing antibody and uses thereof

Broadly neutralizing antibody and uses thereof

Rapid elicitation of broadly neutralizing antibodies to HIV Env

HIV-1 broadly neutralizing antibodies

HIV-1 broadly neutralizing antibodies

UNIV CALIFORNIA

Antibodies specific for native PrPSc

Antibodies specific for native PrPSc

Antibodies specific for native PrPSc

Antibodies specific for ungulate PrP

Antibodies specific for native PrPsc

SCOTGEN BIOPHARMACEUTICALS INC

Antibodies with altered effector functions

CHAN-HUI PO-YING

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

INT AIDS VACCINE INITIATIVE INC

Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies